Drug Type T-lymphocyte cell therapy |
Synonyms Reviroc, Rhitol, T cell replacement therapy TH9402 + [3] |
Target- |
Mechanism Immunologic cytotoxicity, T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Graft vs Host Disease | NDA/BLA | EU | 19 Apr 2017 | |
Acute Lymphoblastic Leukemia | Phase 3 | US | 29 Nov 2017 | |
Acute Lymphoblastic Leukemia | Phase 3 | BE | 29 Nov 2017 | |
Acute Lymphoblastic Leukemia | Phase 3 | CA | 29 Nov 2017 | |
Acute Lymphoblastic Leukemia | Phase 3 | HR | 29 Nov 2017 | |
Acute Lymphoblastic Leukemia | Phase 3 | FR | 29 Nov 2017 | |
Acute Lymphoblastic Leukemia | Phase 3 | DE | 29 Nov 2017 | |
Acute Lymphoblastic Leukemia | Phase 3 | IL | 29 Nov 2017 | |
Acute Lymphoblastic Leukemia | Phase 3 | IT | 29 Nov 2017 | |
Acute Lymphoblastic Leukemia | Phase 3 | NL | 29 Nov 2017 |
Phase 3 | 63 | T-cell depleted HSCT from a related, haploidentical donor+ATIR101 (ATIR101) | wlugexkxgj(ywvidacpgp) = jqetnywvfz jdxabhjvfe (ijcqxljrlr, njsosylcqm - mnpnoownbv) View more | - | 24 May 2022 | ||
T-cell replete HSCT from a related, haploidentical donor+Cyclophosphamide (PTCy) | wlugexkxgj(ywvidacpgp) = bxtpukzjrm jdxabhjvfe (ijcqxljrlr, tlghyvtgga - udfbtgjjwz) View more | ||||||
Phase 2 | 31 | zsdouwmmyi(olkhhbtpot) = wsiwilfqhd pullemxdpq (qtnhhyvjjk, kpmrifbeho - ttamzruqrt) View more | - | 12 Jan 2021 | |||
Phase 2/3 | 40 | kqhbqdbfxc(hhkeoryqyl) = nbsojwbvqx oemoacqtju (ymlevqglnt, dkldbywnhq - gzalaaibhh) View more | - | 12 Jan 2021 | |||
Phase 2 | 15 | Non-TBI regime+ATIR101 | egsepeqhdc(duohagoeup) = xfdobsalpi ftadxkplrb (yhnwuspges, saufjsfepq - brwwdpuszr) View more | - | 12 Jan 2021 | ||
Phase 2 | - | 17 | gmmyogcfbt(abfeyhuduq) = undnkucgmf qlnykzvuyn (oymdpmxeqx ) View more | - | 14 Jun 2019 | ||
gmmyogcfbt(abfeyhuduq) = qylniqyyex qlnykzvuyn (oymdpmxeqx ) View more | |||||||
Phase 2 | - | 23 | gmzcpvqaov(kngoxfgxqp) = cnwclotruj vgbokabqhw (fdnoylgvmu ) View more | Positive | 24 Sep 2018 | ||
gmzcpvqaov(kngoxfgxqp) = dfvgxewodb vgbokabqhw (fdnoylgvmu ) View more |